{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:05:23Z","timestamp":1790413523479,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s00380-024-02416-3","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T11:01:36Z","timestamp":1716462096000},"page":"921-927","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical outcomes and risk factors associated with drug-coated balloon treatment for femoropopliteal artery disease in patients on maintenance hemodialysis"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5111-3361","authenticated-orcid":false,"given":"Ryuta","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiko","family":"Kakuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"issue":"3","key":"2416_CR1","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1161\/01.CIR.0000114519.75433.DD","volume":"109","author":"AM O'Hare","year":"2004","unstructured":"O\u2019Hare AM, Glidden DV, Fox CS, Hsu CY (2004) High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999\u20132000. Circulation 109(3):320\u2013323","journal-title":"Circulation"},{"issue":"3","key":"2416_CR2","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jvs.2017.12.048","volume":"68","author":"A Meyer","year":"2018","unstructured":"Meyer A, Fiessler C, Stavroulakis K, Torsello G, Bisdas T, LangCRITISCH collaborators W (2018) Outcomes of dialysis patients with critical limb ischemia after revascularization compared with patients with normal renal function. J Vasc Surg 68(3):822\u2013829","journal-title":"J Vasc Surg"},{"issue":"8","key":"2416_CR3","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/1538574418789036","volume":"52","author":"A Meyer","year":"2018","unstructured":"Meyer A, Schilling A, Kott M, Rother U, Lang W, Regus S (2018) Open versus endovascular revascularization of below-knee arteries in patients with end-stage renal disease and critical limb ischemia. Vasc Endovascular Surg 52(8):613\u2013620","journal-title":"Vasc Endovascular Surg"},{"issue":"4","key":"2416_CR4","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jvs.2018.12.054","volume":"70","author":"B Ramanan","year":"2019","unstructured":"Ramanan B, Jeon-Slaughter H, Chen X, Modrall JG, Tsai S (2019) Comparison of open and endovascular procedures in patients with critical limb ischemia on dialysis. J Vasc Surg 70(4):1217\u20131224","journal-title":"J Vasc Surg"},{"issue":"9","key":"2416_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"V Aboyans","year":"2018","unstructured":"Aboyans V, Ricco JB, Bartelink MEL, Bj\u00f6rck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, R\u00f6ther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I, ESC Scientific Document Group (2018) 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 39(9):763\u2013816","journal-title":"Eur Heart J"},{"issue":"6S","key":"2416_CR6","doi-asserted-by":"publisher","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","volume":"69","author":"MS Conte","year":"2019","unstructured":"Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR, Murad MH, GVG Writing Group (2019) Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg 69(6S):3S-125S","journal-title":"J Vasc Surg"},{"issue":"1","key":"2416_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","volume":"11","author":"PA Schneider","year":"2018","unstructured":"Schneider PA, Laird JR, Tepe G, Brodmann M, Zeller T, Scheinert D, Metzger C, Micari A, Sachar R, Jaff MR, Wang H, Hasenbank MS, Krishnan P, IN.PACT SFA Trial Investigators (2018) Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial. Circ Cardiovasc Interv 11(1):e005891","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"2416_CR8","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ahj.2014.11.016","volume":"169","author":"MR Jaff","year":"2015","unstructured":"Jaff MR, Rosenfield K, Scheinert D, Rocha-Singh K, Benenati J, Nehler M, White CJ (2015) Drug-coated balloons to improve femoropopliteal artery patency: rationale and design of the LEVANT 2 trial. Am Heart J 169(4):479\u2013485","journal-title":"Am Heart J"},{"issue":"10","key":"2416_CR9","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jcin.2021.03.021","volume":"14","author":"R Sachar","year":"2021","unstructured":"Sachar R, Soga Y, Ansari MM, Kozuki A, Lopez L, Brodmann M, Schro\u00eb H, Ramanath VS, Diaz-Cartelle J, Zeller T, RANGER II SFA Investigators (2021) 1-year results from the ranger ii sfa randomized trial of the ranger drug-coated balloon. JACC Cardiovasc Interv 14(10):1123\u20131133","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"2416_CR10","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1177\/1526602818803119","volume":"25","author":"GM Ansel","year":"2018","unstructured":"Ansel GM, Brodmann M, Keirse K, Micari A, Jaff MR, Rocha-Singh K, Fernandez EJ, Wang H, Zeller T, IN.PACT Global Study Investigators (2018) Drug-Coated Balloon Treatment of Femoropopliteal Lesions Typically Excluded From Clinical Trials: 12-Month Findings From the IN.PACT Global Study. J Endovasc Ther 25(6):673\u2013682","journal-title":"J Endovasc Ther"},{"issue":"1","key":"2416_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s42155-022-00329-8","volume":"5","author":"N Hayakawa","year":"2022","unstructured":"Hayakawa N, Takahara M, Nakama T, Horie K, Takanashi K, Kanagami T, Ichihara S, Arakawa M, Tobita K, Mori S, Iwata Y, Suzuki K, Kanda J (2022) Clinical outcome of drug-coated balloons in patients with femoropopliteal chronic total occlusive lesions: results from the multicenter EAGLE study. CVIR Endovasc 5(1):51","journal-title":"CVIR Endovasc"},{"issue":"5","key":"2416_CR12","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","volume":"173","author":"K Rockwood","year":"2005","unstructured":"Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ 173(5):489\u2013495","journal-title":"CMAJ"},{"issue":"6","key":"2416_CR13","doi-asserted-by":"publisher","first-page":"E212","DOI":"10.1002\/ccd.25387","volume":"83","author":"KJ Rocha-Singh","year":"2014","unstructured":"Rocha-Singh KJ, Zeller T, Jaff MR (2014) Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv 83(6):E212\u2013E220","journal-title":"Catheter Cardiovasc Interv"},{"issue":"3","key":"2416_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1177\/1526602817698634","volume":"24","author":"M Fujihara","year":"2017","unstructured":"Fujihara M, Takahara M, Sasaki S, Nanto K, Utsunomiya M, Iida O, Yokoi Y (2017) Angiographic dissection patterns and patency outcomes after balloon angioplasty for superficial femoral artery disease. J Endovasc Ther 24(3):367\u2013375","journal-title":"J Endovasc Ther"},{"issue":"5","key":"2416_CR15","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1177\/1526602820931477","volume":"27","author":"G Torsello","year":"2020","unstructured":"Torsello G, Stavroulakis K, Brodmann M, Micari A, Tepe G, Veroux P, Benko A, Choi D, Vermassen FEG, Jaff MR, Guo J, Dobranszki R, Zeller T, Global Investigators INPACT (2020) Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort. J Endovasc Ther 27(5):693\u2013705","journal-title":"J Endovasc Ther"},{"issue":"16","key":"2416_CR16","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.jcin.2017.04.041","volume":"10","author":"M Thieme","year":"2017","unstructured":"Thieme M, Von Bilderling P, Paetzel C, Karnabatidis D, Perez Delgado J, Lichtenberg M, Lutonix Global SFA Registry Investigators (2017) The 24-Month Results of the Lutonix Global SFA Registry: Worldwide Experience with Lutonix Drug-Coated Balloon. JACC Cardiovasc Interv 10(16):1682\u20131690","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"2416_CR17","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1253\/circj.CJ-18-0077","volume":"82","author":"HH Chou","year":"2018","unstructured":"Chou HH, Huang HL, Hsieh CA, Jang SJ, Tzeng IS, Ko YL (2018) Drug-coated balloon vs conventional balloon angioplasty in dialysis patients with symptomatic femoropopliteal disease- a matched comparison. Circ J 82(7):1908\u20131916","journal-title":"Circ J"},{"issue":"18","key":"2416_CR18","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1056\/NEJMoa051303","volume":"354","author":"M Schillinger","year":"2006","unstructured":"Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E (2006) Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354(18):1879\u20131888","journal-title":"N Engl J Med"},{"issue":"3","key":"2416_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1161\/CIRCINTERVENTIONS.109.903468","volume":"3","author":"JR Laird","year":"2010","unstructured":"Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR, RESILIENT Investigators (2010) Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 3(3):267\u2013276","journal-title":"Circ Cardiovasc Interv"},{"issue":"9","key":"2416_CR20","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1007\/s00380-015-0740-7","volume":"31","author":"M Fujihara","year":"2016","unstructured":"Fujihara M, Higashimori A, Kato Y, Taniguchi H, Iwasaki Y, Amano T, Sumiyoshi A, Nishiya D, Yokoi Y (2016) Nitinol stent implantation for femoropopliteal disease in patients on hemodialysis: results of the 3-year retrospective multicenter APOLLON study. Heart Vessels 31(9):1476\u20131483","journal-title":"Heart Vessels"},{"issue":"2","key":"2416_CR21","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/ccd.29372","volume":"97","author":"R Ito","year":"2021","unstructured":"Ito R, Ishii H, Oshima S, Nakayama T, Takahashi H, Sakakibara T, Kakuno M, Murohara T (2021) Long-term clinical outcomes after self-expandable bare nitinol stent implantation for femoropopliteal occlusive disease in hemodialysis patients. Catheter Cardiovasc Interv 97(2):318\u2013324","journal-title":"Catheter Cardiovasc Interv"},{"issue":"3","key":"2416_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jacc.2022.10.016","volume":"81","author":"MH Shishehbor","year":"2023","unstructured":"Shishehbor MH, Scheinert D, Jain A, Brodmann M, Tepe G, Ando K, Krishnan P, Iida O, Laird JR, Schneider PA, Rocha-Singh KJ, Zeller T (2023) Comparison of drug-coated balloons vs bare-metal stents in patients with femoropopliteal arterial disease. J Am Coll Cardiol 81(3):237\u2013249","journal-title":"J Am Coll Cardiol"},{"key":"2416_CR23","doi-asserted-by":"publisher","DOI":"10.1177\/15266028231209234","author":"N Kurata","year":"2023","unstructured":"Kurata N, Iida O, Takahara M, Asai M, Okamoto S, Ishihara T, Nanto K, Tsujimura T, Hata Y, Toyoshima T, Higashino N, Nakao S, Mano T (2023) Comparing predictors influencing restenosis following high-dose drug-coated balloon angioplasty and fluoropolymer-based drug-eluting stenting in femoropopliteal artery lesions. J Endovasc Ther. https:\/\/doi.org\/10.1177\/15266028231209234","journal-title":"J Endovasc Ther"},{"issue":"6","key":"2416_CR24","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jcin.2022.01.019","volume":"15","author":"O Iida","year":"2022","unstructured":"Iida O, Takahara M, Soga Y, Yamaoka T, Fujihara M, Kawasaki D, Ichihashi S, Kozuki A, Nanto S, Sakata Y, Mano T, CAPSICUM Investigators (2022) 1-year outcomes of fluoropolymer-based drug-eluting stent in femoropopliteal practice: predictors of restenosis and aneurysmal degeneration. JACC Cardiovasc Interv 15(6):630\u2013638","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"2416_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrcardio.2013.165","volume":"11","author":"RA Byrne","year":"2014","unstructured":"Byrne RA, Joner M, Alfonso F, Kastrati A (2014) Drug-coated balloon therapy in coronary and peripheral artery disease. Nat Rev Cardiol 11(1):13\u201323","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"2416_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.025677","volume":"12","author":"Y Soga","year":"2023","unstructured":"Soga Y, Takahara M, Iida O, Tomoi Y, Kawasaki D, Tanaka A, Yamauchi Y, Tobita K, Kozuki A, Fujihara M, Ando K, POPCORN Investigators (2023) Vessel patency and associated factors of drug-coated balloon for femoropopliteal lesion. J Am Heart Assoc 12(1):e025677","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"2416_CR27","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/s00380-021-01970-4","volume":"37","author":"T Shimada","year":"2022","unstructured":"Shimada T, Shima Y, Takahashi K, Miura K, Takamatsu M, Ikuta A, Habara S, Tanaka H, Goto T, Izumiya Y, Kadota K (2022) Delayed stenosis regression after drug-coated balloon angioplasty for femoropopliteal artery lesions. Heart Vessels 37(5):730\u2013737","journal-title":"Heart Vessels"},{"issue":"5","key":"2416_CR28","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/ccd.30622","volume":"101","author":"S Mori","year":"2023","unstructured":"Mori S, Takahara M, Nakama T, Tobita K, Hayakawa N, Iwata Y, Horie K, Suzuki K, Yamawaki M, Ito Y (2023) Impact of calcification on clinical outcomes after drug-coated balloon angioplasty for superficial femoral artery disease: assessment using the peripheral artery calcification scoring system. Catheter Cardiovasc Interv 101(5):892\u2013899","journal-title":"Catheter Cardiovasc Interv"},{"issue":"11","key":"2416_CR29","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1007\/s00380-023-02284-3","volume":"38","author":"S Mori","year":"2023","unstructured":"Mori S, Yamawaki M, Fukagawa T, Yamaguchi K, Mizusawa M, Shirai S, Honda Y, Tsutsumi M, Kobayashi N, Ito Y (2023) Impact of \u201cblack rock\u201d on clinical outcomes after endovascular therapy for de novo calcified femoropopliteal lesions. Heart Vessels 38(11):1356\u20131363","journal-title":"Heart Vessels"},{"key":"2416_CR30","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2147\/VHRM.S371177","volume":"18","author":"NW Shammas","year":"2022","unstructured":"Shammas NW, Purushottam B, Shammas WJ, Christensen L, Shammas G, Weakley D, Jones-Miller S, JET-RANGER Investigators (2022) Jetstream atherectomy followed by paclitaxel-coated balloons versus balloon angioplasty followed by paclitaxel-coated balloons: twelve-month exploratory results of the prospective randomized JET-RANGER study. Vasc Health Risk Manag 18:603\u2013615","journal-title":"Vasc Health Risk Manag"},{"key":"2416_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/VHRM.S403177","volume":"19","author":"NW Shammas","year":"2023","unstructured":"Shammas NW, Shammas G, Christensen L, Jones-Miller S, Investigators JET-RANGER (2023) Jetstream atherectomy with paclitaxel-coated balloons: two-year outcome of the prospective randomized JET-RANGER study. Vasc Health Risk Manag 19:133\u2013137","journal-title":"Vasc Health Risk Manag"},{"issue":"1","key":"2416_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/15266028211058683","volume":"29","author":"K Horie","year":"2022","unstructured":"Horie K, Tanaka A, Taguri M, Inoue N (2022) Impact of baseline and postprocedural intravascular ultrasound findings on 1-year primary patency after drug-coated balloon treatment of femoropopliteal lesions. J Endovasc Ther 29(1):66\u201375","journal-title":"J Endovasc Ther"},{"issue":"2","key":"2416_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/15266028221081082","volume":"30","author":"N Kurata","year":"2023","unstructured":"Kurata N, Iida O, Takahara M, Asai M, Masuda M, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujimura T, Matsuda Y, Hata Y, Mano T (2023) Clinical impact of the size of drug-coated balloon therapy on restenosis rate in femoropopliteal lesions. J Endovasc Ther 30(2):269\u2013280","journal-title":"J Endovasc Ther"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-024-02416-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00380-024-02416-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-024-02416-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T12:04:37Z","timestamp":1729253077000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00380-024-02416-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["2416"],"URL":"https:\/\/doi.org\/10.1007\/s00380-024-02416-3","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]},"assertion":[{"value":"12 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Ethics Committee of Nagoya Kyoritsu Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"H.I. received lecture fees from Astellas Pharma Inc., Astrazeneca Inc., Bayer Pharmaceutical Co., Ltd., Bristol-Myers Squibb Inc., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Pharma Inc., and MSD K. K. T.M. received lecture fees from Bayer Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K.K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K.K., Pfizer Japan Inc., Sanofi-aventis K.K., and Takeda Pharmaceutical Co., Ltd. The remaining authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}